155 related articles for article (PubMed ID: 34078088)
1. Is there a role for immune checkpoint inhibitors in chordoma?
Assi T
Immunotherapy; 2021 Aug; 13(12):967-970. PubMed ID: 34078088
[No Abstract] [Full Text] [Related]
2. Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
Starzer AM; Berghoff AS; Hamacher R; Tomasich E; Feldmann K; Hatziioannou T; Traint S; Lamm W; Noebauer-Huhmann IM; Furtner J; Müllauer L; Amann G; Bauer S; Schildhaus HU; Preusser M; Heller G; Brodowicz T
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762319
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of advanced chordomas.
Colia V; Stacchiotti S
Eur J Cancer; 2017 Sep; 83():220-228. PubMed ID: 28750274
[TBL] [Abstract][Full Text] [Related]
4. Chordoma.
Hueng DY; Ma HI; Sytwu HK
J Neurosurg Spine; 2013 May; 18(5):533-4. PubMed ID: 23414004
[No Abstract] [Full Text] [Related]
5. Response. Chordoma.
Bayrak OF; Gulluoglu S; Aydemir E
J Neurosurg Spine; 2013 May; 18(5):534. PubMed ID: 23776939
[No Abstract] [Full Text] [Related]
6. Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Schuetze SM; Bolejack V; Choy E; Ganjoo KN; Staddon AP; Chow WA; Tawbi HA; Samuels BL; Patel SR; von Mehren M; D'Amato G; Leu KM; Loeb DM; Forscher CA; Milhem MM; Rushing DA; Lucas DR; Chugh R; Reinke DK; Baker LH
Cancer; 2017 Jan; 123(1):90-97. PubMed ID: 27696380
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for immune checkpoint inhibitors in selected rare subtypes of soft tissue sarcoma?
Assi T; Cesne AL; Mir O
Immunotherapy; 2021 Feb; 13(2):91-93. PubMed ID: 33291976
[No Abstract] [Full Text] [Related]
8. Pathologic complete response to preoperative immunotherapy in a lung adenocarcinoma patient with bone metastasis: A case report.
Tang Y; Li Y; Zhang L; Tong G; Ou Z; Wang Z; Zhang H; Qiao G
Thorac Cancer; 2020 Apr; 11(4):1094-1098. PubMed ID: 32077636
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary metastatic chordoma improved by platinum-based chemotherapy.
Lee MH; Kim SR; Jeong JS; Lee EJ; Lee YC
Lung Cancer; 2012 May; 76(2):255-7. PubMed ID: 22398139
[TBL] [Abstract][Full Text] [Related]
10. Brachyury: Strategies for Drugging an Intractable Cancer Therapeutic Target.
Robinson H; McFarlane RJ; Wakeman JA
Trends Cancer; 2020 Apr; 6(4):271-273. PubMed ID: 32209441
[TBL] [Abstract][Full Text] [Related]
11. Effective use of thalidomide in the treatment of recurrent metastatic chordoma.
Chay WY; Teo M; Sittampalam K; Toh HC
J Clin Oncol; 2011 Jun; 29(16):e477-80. PubMed ID: 21444873
[No Abstract] [Full Text] [Related]
12. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
[TBL] [Abstract][Full Text] [Related]
13. PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma.
Scheinberg T; Lomax A; Tattersall M; Thomas D; McCowage G; Sullivan M; Karim R; Luk PP; Mahar A; Bonar F; Bhadri VA
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1327. PubMed ID: 33314769
[TBL] [Abstract][Full Text] [Related]
14. Durable stabilization of three chordoma cases by bevacizumab and erlotinib.
Asklund T; Sandström M; Shahidi S; Riklund K; Henriksson R
Acta Oncol; 2014 Jul; 53(7):980-4. PubMed ID: 24456503
[No Abstract] [Full Text] [Related]
15. Chordoma: a case series and review of the literature.
Alan O; Akin Telli T; Ercelep O; Tanrikulu Simsek E; Basoglu Tuylu T; Mutis A; Hasanov R; Kaya S; Akgül Babacan N; Dane F; Yumuk PF
J Med Case Rep; 2018 Aug; 12(1):239. PubMed ID: 30145982
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review.
Launay SG; Chetaille B; Medina F; Perrot D; Nazarian S; Guiramand J; Moureau-Zabotto L; Bertucci F
BMC Cancer; 2011 Oct; 11():423. PubMed ID: 21970335
[TBL] [Abstract][Full Text] [Related]
17. Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study.
Stacchiotti S; Morosi C; Lo Vullo S; Casale A; Palassini E; Frezza AM; Dinoi G; Messina A; Gronchi A; Cavalleri A; Venturelli E; Morelli D; Pilotti S; Collini P; Brich S; Tamborini E; Mariani L; Casali PG
Cancer; 2018 Oct; 124(20):4056-4063. PubMed ID: 30216418
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the endolysosomal system in human chordoma cell lines: is there a role of lysosomes in chemoresistance of this rare bone tumor?
Kolb-Lenz D; Fuchs R; Lohberger B; Heitzer E; Meditz K; Pernitsch D; Pritz E; Groselj-Strele A; Leithner A; Liegl-Atzwanger B; Rinner B
Histochem Cell Biol; 2018 Jul; 150(1):83-92. PubMed ID: 29725750
[TBL] [Abstract][Full Text] [Related]
19. Metastatic chordoma: pattern of spread and response to chemotherapy.
Ashwood N; Hoskin PJ; Saunders MI
Clin Oncol (R Coll Radiol); 1994; 6(5):341-2. PubMed ID: 7826929
[TBL] [Abstract][Full Text] [Related]
20. Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review.
Liang S; Yang J; Lin Y; Li T; Zhao W; Zhao J; Dong C
Front Immunol; 2021; 12():682262. PubMed ID: 34305915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
